Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Der Urologe. Ausg. A|December 19, 2015
[Salvage lymphadenectomy in patients with prostate cancer recurrence: A review]D K Osmonov, A V Aksenov, C A Jilg, et al.The Journal of Urology|October 23, 2012
Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancerC A Jilg, H C Rischke, S N Reske, et al.Cancer Immunology, Immunotherapy : CII|June 21, 2007
A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cellsP Bühler, P Wolf, D Gierschner, et al.International Journal of Cancer|January 27, 1997
A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancerH Veelken, A Mackensen, M Lahn, et al.Prostate Cancer and Prostatic Diseases|July 16, 2021
Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days' follow-upTobias Kohl, August Sigle, Timur Kuru, et al.European Urology Focus|March 14, 2018
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control StudyT Steuber, C Jilg, P Tennstedt, et al.Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 20, 2007
[Von Hippel-Lindau disease. Interdisciplinary patient care]H P H Neumann, M Cybulla, S Gläsker, et al.The Journal of Urology|September 29, 1998
Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinomaH P Neumann, B U Bender, D P Berger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2004
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trialA R Zander, N Kröger, C Schmoor, et al.Der Urologe. Ausg. A|November 1, 2015
[Treatment mapping of prostate cancer in DVPZ prostate centers in Germany]R Berges, T Ebert, W Schafhauser, et al.Pageof 7